31 May 2023FeaturesPatentsJamie Atkins and Abi Heath
Enlarged Board of Appeal tackles entitlement to priority
It is certainly an exciting time at the EPO—barely two months have passed since the long awaited “plausibility” decision ( G 2/21), and the EPO Enlarged Board of Appeal (EBA) has just held oral proceedings to help it decide on another highly anticipated referral—this time on legal entitlement to priority ( G 1/22 and G 2/22).
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
27 June 2023 An EPO Board of Appeal finding could be construed as loosening the requirements for establishing novelty, explains Jonathan Foster and James Clegg.
18 July 2023 Side letter to CPTPP agreement allows UK to opt-out of grace period for patents | No new action required on pharmaceutical patents or GIs.
25 July 2023 Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.
18 November 2024 Following the High Court’s long-awaited WaterRower decision, WIPR met with Rachel Pearse of Gunnercooke, part of the winning team, to explore what the “fascinating” case means for designers.